Genmab A/S
Hedge Funds Holdings
Last updated:
Genmab A/S‘s stocks are currently a part of 143 hedge funds’ portfolios, which represents 37.47% of the total amount of its stocks outstanding. This makes up a total of 24.73M shares of Genmab A/S. Compared to the previous quarter, the number fell by -45.89% or -20.97M shares fewer. As for the holding position changes, 36.36% (52) of current hedge fund investors increased the number of shares held, 42.66% (61) of current holders sold a part of the shares held, and 20.28% (29) closed the holdings completely. 19 hedge funds are new holders of Genmab A/S stock in Q1 2023, it is 13.29% of total holders.
Hedge funds holding Genmab A/S (Q2 2018 – Q1 2023)
| Q2 2018 | 5 |
|---|---|
| Q3 2018 | 6 |
| Q4 2018 | 6 |
| Q1 2019 | 8 |
| Q2 2019 | 7 |
| Q3 2019 | 94 |
| Q4 2019 | 127 |
| Q1 2020 | 138 |
| Q2 2020 | 171 |
| Q3 2020 | 194 |
| Q4 2020 | 219 |
| Q1 2021 | 202 |
| Q2 2021 | 204 |
| Q3 2021 | 202 |
| Q4 2021 | 204 |
| Q1 2022 | 197 |
| Q2 2022 | 172 |
| Q3 2022 | 187 |
| Q4 2022 | 228 |
| Q1 2023 | 143 |
Hedge funds changes in Genmab A/S positions (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 2 | 2 | 0 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 1 | 2 | 3 | 0 | 0 |
| Q4 2018 | 1 | 3 | 1 | 1 | 0 |
| Q1 2019 | 2 | 5 | 0 | 0 | 1 |
| Q2 2019 | 1 | 3 | 2 | 2 | -1 |
| Q3 2019 | 88 | 4 | 0 | 1 | 1 |
| Q4 2019 | 47 | 40 | 26 | 12 | 2 |
| Q1 2020 | 29 | 50 | 45 | 17 | -3 |
| Q2 2020 | 52 | 64 | 41 | 19 | -5 |
| Q3 2020 | 42 | 83 | 51 | 18 | 0 |
| Q4 2020 | 50 | 86 | 59 | 22 | 2 |
| Q1 2021 | 32 | 77 | 68 | 48 | -23 |
| Q2 2021 | 41 | 81 | 53 | 38 | -9 |
| Q3 2021 | 27 | 97 | 52 | 26 | 0 |
| Q4 2021 | 30 | 67 | 82 | 26 | -1 |
| Q1 2022 | 22 | 72 | 81 | 27 | -5 |
| Q2 2022 | 15 | 57 | 80 | 37 | -17 |
| Q3 2022 | 38 | 76 | 59 | 22 | -8 |
| Q4 2022 | 63 | 71 | 79 | 19 | -4 |
| Q1 2023 | 19 | 52 | 61 | 29 | -18 |
Hedge funds changes in Genmab A/S stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 256,000 |
| Q2 2020 | 3,023,000 | 604,000 |
| Q3 2020 | 5,496,000 | 1,977,000 |
| Q4 2020 | 3,574,000 | 3,444,000 |
| Q1 2021 | 4,107,000 | 7,006,000 |
| Q2 2021 | 4,957,000 | 3,038,000 |
| Q3 2021 | 6,776,000 | 931,000 |
| Q4 2021 | 261,000 | 265,000 |
| Q1 2022 | 847,000 | 0 |
| Q2 2022 | 4,406,000 | 0 |
| Q3 2022 | 6,555,000 | 0 |
| Q4 2022 | 1,089,166 | 1,216,306 |
| Q1 2023 | 3,776,000 | 0 |